Latest Market Segmentation News

Page 2 of 17
AnteoTech has marked significant progress in battery and life sciences sectors, highlighted by a major capital raise and strategic US partnership. The company is poised to convert promising trials into sales amid expanding market opportunities.
Victor Sage
Victor Sage
30 Jan 2026
Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.
Ada Torres
Ada Torres
29 Jan 2026
First Graphene and UK manufacturer FP McCann have successfully produced the first batch of graphene-enhanced concrete roof tiles, marking a significant step toward low-carbon, high-performance construction materials in the UK housing sector.
Maxwell Dee
Maxwell Dee
29 Jan 2026
CurveBeam AI reported steady progress in Q2 FY26 with five new device purchase orders, a $4 million milestone payment pending receipt, and key regulatory submissions underway in the US and China.
Ada Torres
Ada Torres
29 Jan 2026
Spenda Limited reports a 65% year-on-year jump in payment volumes and a 34% quarterly rise in cash receipts, alongside significant cost savings and leadership changes.
Sophie Babbage
Sophie Babbage
28 Jan 2026
Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.
Ada Torres
Ada Torres
28 Jan 2026
Australian Dairy Nutritionals Limited (AHF) is raising approximately $3.47 million through a pro-rata entitlement offer to accelerate its growth plans in China and enhance processing efficiency.
Victor Sage
Victor Sage
27 Jan 2026
MONEYME has secured an exclusive partnership with Luxury Escapes to issue a co-branded credit card in Australia, aiming to blend travel rewards with digital-first credit services.
Claire Turing
Claire Turing
27 Jan 2026
Savana Asset Management’s SVNP ETF delivered a standout 12.9% net return in 2025, outperforming major US equity ETFs despite a volatile year marked by geopolitical tensions and AI-driven market narratives.
Claire Turing
Claire Turing
22 Jan 2026
Osteopore Limited has inked a three-year exclusive distribution agreement with MontsMed to introduce its advanced orthopaedic trauma reconstruction products into Hong Kong, positioning itself strategically within the Greater Bay Area.
Ada Torres
Ada Torres
22 Jan 2026
Qoria Limited has reported a record-breaking quarter with annual recurring revenue exceeding US$100 million and a 42% increase in net ARR for Q2 FY2026, reaffirming its strong growth trajectory and FY26 guidance.
Sophie Babbage
Sophie Babbage
20 Jan 2026
Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.
Claire Turing
Claire Turing
16 Jan 2026